Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
IGF-1 LR3 versus IGF-1 DES Another common IGF-1 variant, IGF-1 DES (Des 1-3), takes the opposite approach to modification
Preclinical (animal) data Rodent studies suggest BPC-157 may: Promote blood vessel growth Enhance tendon fibroblast activity Reduce inflammation Protect gastrointestinal tissues However, these findings: Use doses far above any human equivalent Use controlled laboratory injuries Do not predict human efficacy 2
This further protects it from any residual moisture or freezer burn
Never shake vigorous agitation can fragment the longer CJC-1295 peptide chain
BPC-157 shows significant potential for fibromyalgia management through its anti-inflammatory and tissue healing properties
Blood 116, 39233932
